Non-Alcoholic Steatohepatitis (NASH) Pipeline Insight, 2024 Featuring 100+ Companies and 110+ Pipeline Drugs Including Lanifibranor (Inventiva Pharma), MSDC-0602K (Cirius Therapeutics), TERN-501 (Terns Pharma)
02 mai 2024 07h25 HE
|
Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Research Report 20254: Patient Pool Analysis, Market Size and Market Forecasts 2020-2034
13 févr. 2024 09h50 HE
|
Research and Markets
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The "Nonalcoholic Steatohepatitis (NASH) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ...
Japan Non-Alcoholic Steatohepatitis (NASH) Market Forecast 2023-2032: Emerging Therapies & Treatment Insights, Comprehensive Market Outlook, Expert & Qualitative Analyses
30 janv. 2024 07h09 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Japan Non-Alcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast - 2032" report has been added to ...
Challenges in Non-Alcoholic Steatohepatitis (NASH) Diagnosis and Lack of Definitive Methods Hamper Market Growth Despite Rising Awareness
10 nov. 2023 08h23 HE
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential...
NASH Treatment & Therapeutics market is projected to grow at a CAGR of 38.6% by 2033: Visiongain
13 sept. 2023 09h04 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled NASH Treatment & Therapeutics Market Report 2023-2033: Forecasts by Product Type (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib,...
$5.5+ Billion Non-Alcoholic Steatohepatitis Market by Drug Type, Disease Cause, Sales Channel - Global Forecasts to 2028
08 sept. 2023 09h53 HE
|
Research and Markets
Dublin, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The "Non-Alcoholic Steatohepatitis Market by Drug Type, Disease Cause, Sales Channel, End User, and Region 2023-2028" report has been added to ...
Non Alcoholic Steatohepatitis (NASH) Market Size & Share to Surpass $21879 Million by 2028 | Vantage Market Research
04 avr. 2023 08h31 HE
|
Vantage Market Research
WASHINGTON, April 04, 2023 (GLOBE NEWSWIRE) -- The Global Non Alcoholic Steatohepatitis (NASH) Market is valued at USD 1,569 Million in 2021 and is projected to reach a value of USD 21,879 Million...
Global Non-Alcoholic Steatohepatitis Market Report to 2027 - Featuring Intercept Pharmaceuticals, Novartis, Siemens Healthineers and AstraZeneca Among Others
09 janv. 2023 04h23 HE
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "Global Non-Alcoholic Steatohepatitis Market: Analysis By Drug Type, By Application Type, By Distribution Type, By Region Size and Trends with Impact of...
Global non-alcoholic fatty liver disease & NASH market is projected to reach at a market value of US$62.06 Billion by 2031: Visiongain Research Inc
12 avr. 2022 10h35 HE
|
Visiongain Ltd
Global Non-alcoholic Fatty Liver Disease & NASH Market Forecast 2021-2031: - By Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity, Other Disease Causes) By...
Endoscopy Devices for Obesity, Type II Diabetes and NASH Market to Garner $3.71 Billion by 2028: AMR
08 juil. 2021 08h23 HE
|
Allied Market Research
Portland, OR, July 08, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Endoscopy Devices for Obesity, Type II Diabetes and Nash Market generate $2.63...